House:
ADJOURNED 'til Monday at 11 a.m. (Informal)
Senate:
ADJOURNED 'til Monday at 11 a.m. (No Calendar)

Vaccine Developers Feel Impacts of Being in Spotlight

From left to right: messagingLAB founder and CEO Karl Schmieder; Bill and Melinda Gates Foundation Medical Research Institute Discovery Leader Jared Silverman; MilliporeSigma Head of Process Solutions Services Research and Development Audrey Chang; and consultant David Onions speak during a virtual panel on vaccine development Thursday. [Screenshot]

With pharmaceutical companies racing to find a COVID-19 vaccine and the world closely watching their progress, scientific experts stressed Thursday that the clinical trial process must play out in full before a safe immunization can reach the public.

Get the rest of the story!

State House News Service subscribers include media outlets, corporations, non-profits and law offices of every size. You may request a free 21-day trial of the News Service for your company by submitting the form below.

Note to political campaigns: We do not accept trial requests from campaigns from June 24 through Election Day. However, we would be happy to start a pre-paid subscription for your campaign (except for constitutional offices, congressional offices and statewide campaigns) at a deeply-discounted rate of $23/week, paid through the election. Simply email Martha King to set up this subscription; she'll send you further instructions.

If you are already a subscriber, you can log in here. If you need a username/password reminder, click here.

Request a Free 21-day Trial:


To request a trial for an individual person not affiliated with an organization, please email our Director of Sales, Martha King, at mgking@statehousenews.com or call (617) 507-9977.



Latest DPH COVID-19 Data

COVID-19 Dashboard
Data Dashboard
Response Reporting

SHNS Conference
Committee Scorecard

SHNS Conference Committee Scorecard
Track Latest Conference Updates
 
State House News Service